Attenuation of growth hormone action in mice at a mature adult age (6‐months) extends lifespan, reduces protein oxidation and glomerulonephritis in females while improving insulin sensitivity and decreasing lipid peroxidation, glomerulonephritis, and neoplasms in males. Here, INS is linked to glomerulonephritis.